Upgrade to SI Premium - Free Trial

Amgen (AMGN) Otezla Deal 'Highly Accretive' - Cowen

August 26, 2019 11:44 AM
Cowen analyst Yaron Werber reiterated an Outperform rating and $231.00 price target on Amgen (NASDAQ: AMGN) after the company agreed ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments